A new type of clinical trial aims to identify which drug is the best fit for each patient's tumor. Can this innovative model expedite new drug approvals?

by Sue Rochman

A serendiptious discovery more than 50 years ago heralded a new age of cancer treatment.

by Jocelyn Selim

Forward Look

Q&A with immunologist James P. Allison, Memorial Sloan-Kettering Cancer Center, New York City.

by Ingfei Chen

Survivor Profile

Diagnosed at 28, Rochelle Shoretz has stayed true to her big dreams and to her goal of helping other young women with breast cancer.

by Yvonne Lee

Many patients in urgent need of bone marrow or stem cell transplants are facing uncertainty.

by Karen Patterson

Forward Look

Debate goes on as FDA revokes drug's use for breast cancer.

by Alanna Kennedy-Gorman

Forward Look

Genetic marker discovery could help childhood Hodgkin survivors assess risks associated with radiation.

by Mitzi Baker

Global Report

An American cancer survivor's visit to a Southern African nation reveals how doctors are adapting cancer care to meet an overwhelming need.

by Cynthia Ryan

Patients are increasingly skipping treatment breaks and opting for ongoing treatment known as maintenance therapy to try to keep some types of cancer at bay.

by Melissa Weber

Forward Look

Is the considerable risk-reduction benefit of CT screening worth the potential downsides?

by Sue Rochman